CIK 0001699031
- Non-accelerated filer
- Emerging growth company
GRAIL, Inc.
Sign in to watch- Ticker
- GRAL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 863673636
- Phone
- +1 833-694-2553
- Business address
- 250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
- Former names
- GRAIL, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $15,155,660
- in 8 filings, $10.5M under 10b5-1 plans
Net −$15,155,660. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-15 | SUMME GREGORY L Director | Grant or award | +237 | $135.46 | $32K | 45,909 |
| 2026-07-15 | SUMME GREGORY L Director | Grant or award | +427 | $74.36 | $32K | 45,672 |
| 2026-06-18 | SUMME GREGORY L Director | Grant or award | +5,491 | $63.74 | $350K | 45,245 |
| 2026-04-15 | SUMME GREGORY L Director | Grant or award | +631 | $49.79 | $31K | 39,754 |
| 2026-01-15 | SUMME GREGORY L Director | Grant or award | +329 | $97.44 | $32K | 39,123 |
| 2025-10-15 | SUMME GREGORY L Director | Grant or award | +425 | $75.52 | $32K | 38,794 |
| 2025-07-15 | SUMME GREGORY L Director | Grant or award | +825 | $38.53 | $32K | 38,369 |
| 2025-05-29 | SUMME GREGORY L Director | Grant or award | +6,082 | $41.10 | $250K | 37,544 |
| 2025-04-15 | SUMME GREGORY L Director | Grant or award | +1,212 | $25.94 | $31K | 31,462 |
| 2025-01-15 | SUMME GREGORY L Director | Grant or award | +1,828 | $17.58 | $32K | 30,250 |
| 2024-10-30 | SUMME GREGORY L Director | Grant or award | +296 | $13.62 | $4K | 28,422 |
| 2024-10-15 | SUMME GREGORY L Director | Grant or award | +1,656 | $14.01 | $23K | 28,126 |
| 2024-06-25 | SUMME GREGORY L Director | Grant or award | +26,470 | 26,470 |
Page 1 of 1 · 13 trades